TWO · 6917.TWO
Andros Pharmaceuticals Co.,Ltd
NT$32.25-NT$0.90 (-2.71%)
Andros Pharmaceuticals Co.,Ltd’s quoted price sits in the lower half of its reported 52-week range, 29.82% below the high.
Loading market information…
TWO · 6518.TWO · TWD
Stock price, dividends
Quote as of Oct 30, 2026, 06:01 AM UTC. Cached market data; not a live quote.
One-year closing-price history · TWD. Historical prices are not a forecast.
Concord Medical Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 43.75% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
Concord Medical Co., Ltd.’s forward annual dividend is NT$1.50 per share, paid annual. The forward yield is 4.98% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
THE COMPANY BEHIND THE TICKER
Concord Medical Co., Ltd. delivers extensive support services for hospital administration across Taiwan, Myanmar, and China. The company's portfolio of services includes critical medical management assistance, covering professional training for healthcare staff, the provision of nursing personnel, and general operational guidance. Additionally, Concord Medical offers comprehensive procurement solutions, sourcing a broad spectrum of items such as medical devices, pharmaceuticals, general medical supplies and consumables, as well as specialized inspection equipment and laboratory reagents. Expanding its ventures, the firm also develops and markets its own proprietary brands, which feature aesthetic healthcare products, nutritional supplements, and prepared traditional Chinese medicines. Furthermore, Concord Medical is actively involved in the strategic planning and sales of medical equipment, alongside offering medical apparatus leasing services. Concord Medical Co., Ltd. was established in 2009 and is headquartered in New Taipei City, Taiwan.
Latest available per-share figures in TWD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 12:44 PM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
NT$32.25-NT$0.90 (-2.71%)
Andros Pharmaceuticals Co.,Ltd’s quoted price sits in the lower half of its reported 52-week range, 29.82% below the high.
NT$46.00NT$0.00 (0.0%)
S&S Healthcare Holding Ltd.’s quoted price sits in the upper half of its reported 52-week range, 12.38% below the high.
NT$15.85-NT$0.20 (-1.25%)
Radiant Innovation Inc.’s quoted price sits in the lower half of its reported 52-week range, 24.7% below the high.
NT$16.60-NT$0.30 (-1.78%)
Healthconn Corp.’s quoted price sits in the lower half of its reported 52-week range, 31.97% below the high.
NT$28.35NT$0.00 (0.0%)
BioLASCO Taiwan Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 12.5% below the high.
NT$18.65NT$0.00 (0.0%)
TFBS Bioscience Inc.’s quoted price sits in the lower half of its reported 52-week range, 33.03% below the high.
NT$6.35-NT$0.34 (-5.08%)
PlexBio Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 59.81% below the high.
NT$16.90+NT$0.40 (+2.42%)
SynCore Biotechnology Co.,Ltd’s quoted price sits in the lower half of its reported 52-week range, 41.32% below the high.
